WIM
Woodford Investment Management Portfolio holdings
AUM
$310M
This Quarter Return
+4.42%
1 Year Return
-17.41%
3 Year Return
-27.69%
5 Year Return
+67.02%
10 Year Return
–
AUM
$1.24B
AUM Growth
+$1.24B
(+7.1%)
Cap. Flow
+$69M
Cap. Flow
% of AUM
5.57%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
6
Reduced
–
Closed
1
Top Buys
| 1 |
Theravance Biopharma
TBPH
|
$24.1M |
| 2 |
NCNA
NuCana
NCNA
|
$23.2M |
| 3 |
Biogen
BIIB
|
$17.4M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$16M |
| 5 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
$6.83M |
Top Sells
| 1 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$22.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUTL
1
Autolus Therapeutics
AUTL
$399M
| $379M | 30.59% | 12,041,419 +116,000 | +1% | +$3.65M |
|
|
2
Theravance Biopharma
TBPH
$699M
| $303M | 24.48% | 13,379,979 +1,063,450 | +9% | +$24.1M |
|
|
3
Agios Pharmaceuticals
AGIO
$2.19B
| $149M | 12.06% | 2,214,459 +237,000 | +12% | +$16M |
|
4
Prothena Corp
PRTA
$441M
| $145M | 11.68% | 11,924,614 | – | – |
|
5
Alkermes
ALKS
$4.78B
| $96.3M | 7.78% | 2,639,676 | – | – |
|
|
6
Biogen
BIIB
$19.4B
| $70.9M | 5.73% | 300,040 +73,476 | +32% | +$17.4M |
|
|
NCNA
7
NuCana
NCNA
$6.09M
| $54.9M | 4.43% | 3,230,999 +1,365,999 | +73% | +$23.2M |
|
|
EVFM
8
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $40.4M | 3.26% | 11,543,728 +1,950,531 | +20% | +$6.83M |
|
|
NITE
9
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| – | – | -1,921,315 | Closed | -$22.1M |
|